Coleen Glessner, EVP, Quality & Ethics, and CPL at Emergent BioSolutions Inc. (EBS), sold 30,608 shares at $10.00 ($306K) on 2025-10-07, disclosed to the SEC on 2025-10-16.
Open-market sale of $306k EBS by EVP, Quality & Ethics, and CPL. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.